Low-density lipoprotein and other predictors of response with telaprevir-based therapy in treatment-experienced HCV genotype 1 patients: REALIZE study.
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Predictors of response to treatment with peginterferon plus ribavirin are well established.
In these post-hoc analyses of the REALIZE study, we sought to identify predictors
of response for telaprevir-based triple therapy.